Literature DB >> 28990106

Identification of key genes for diabetic kidney disease using biological informatics methods.

Fuzhe Ma1, Tao Sun1, Meiyan Wu1, Wanning Wang1, Zhonggao Xu1.   

Abstract

Diabetic kidney disease (DKD) is a common complication of diabetes, which is characterized by albuminuria, impaired glomerular filtration rate or a combination of the two. The aim of the present study was to identify the potential key genes involved in DKD progression and to subsequently investigate the underlying mechanism involved in DKD development. The array data of GSE30528 including 9 DKD and 13 control samples was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in DKD glomerular and tubular kidney biopsy tissues were compared with normal tissues, and were analyzed using the limma package. Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed for DEGs using the GO Function software in Bioconductor. The protein‑protein interaction (PPI) network was then constructed using Cytoscape software. A total of 426 genes (115 up‑ and 311 downregulated) were differentially expressed between the DKD and normal tissue samples. The PPI network was constructed with 184 nodes and 335 edges. Vascular endothelial growth factor A (VEGFA), α‑actinin‑4 (ACTN4), proto‑oncogene, Src family tyrosine kinase (FYN), collagen, type 1, α2 (COL1A2) and insulin‑like growth factor 1 (IGF1) were hub proteins. Major histocompatibility complex, class II, DP α1 (HLA‑DPA1) was the common gene enriched in the rheumatoid arthritis and systemic lupus erythematosus pathways, and the immune response was a GO term enriched in module A. VEGFA, ACTN4, FYN, COL1A2, IGF1 and HLA‑DPA1 may be potential key genes associated with the progression of DKD, and immune mechanisms may serve a part in DKD development.

Entities:  

Mesh:

Year:  2017        PMID: 28990106      PMCID: PMC5779875          DOI: 10.3892/mmr.2017.7666

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  48 in total

Review 1.  Leukocyte recruitment and vascular injury in diabetic nephropathy.

Authors:  Elena Galkina; Klaus Ley
Journal:  J Am Soc Nephrol       Date:  2006-01-04       Impact factor: 10.121

2.  Type 1 diabetes mellitus masking primary antibody deficiency.

Authors:  S L Johnston; P F Virgo; D J Unsworth
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

3.  GO-function: deriving biologically relevant functions from statistically significant functions.

Authors:  Jing Wang; Xianxiao Zhou; Jing Zhu; Yunyan Gu; Wenyuan Zhao; Jinfeng Zou; Zheng Guo
Journal:  Brief Bioinform       Date:  2011-06-24       Impact factor: 11.622

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

Authors:  Maja T Lindenmeyer; Matthias Kretzler; Anissa Boucherot; Silvia Berra; Yoshinari Yasuda; Anna Henger; Felix Eichinger; Stefanie Gaiser; Holger Schmid; Maria P Rastaldi; Robert W Schrier; Detlef Schlöndorff; Clemens D Cohen
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

6.  Insulin-like growth factor-1 stimulates production of mesangial cell matrix components.

Authors:  B D Schreiber; M L Hughes; G C Groggel
Journal:  Clin Nephrol       Date:  1995-06       Impact factor: 0.975

Review 7.  Fyn, a Src family tyrosine kinase.

Authors:  M D Resh
Journal:  Int J Biochem Cell Biol       Date:  1998-11       Impact factor: 5.085

Review 8.  Systemic lupus erythematosus: the face of Asia.

Authors:  Pao-Hsii Feng
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

9.  Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

Authors:  B Hohenstein; B Hausknecht; K Boehmer; R Riess; R A Brekken; C P M Hugo
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

10.  PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.

Authors:  Eric Altermann; Todd R Klaenhammer
Journal:  BMC Genomics       Date:  2005-05-03       Impact factor: 3.969

View more
  2 in total

1.  Integrated Analysis of Multiple Microarray Studies to Identify Core Gene-Expression Signatures Involved in Tubulointerstitial Injury in Diabetic Nephropathy.

Authors:  Huandi Zhou; Zhifen Yang; Lin Mu; Yonghong Shi
Journal:  Biomed Res Int       Date:  2022-05-10       Impact factor: 3.246

2.  Epigallocatechin Gallate Induces the Demethylation of Actinin Alpha 4 to Inhibit Diabetic Nephropathy Renal Fibrosis via the NF-KB Signaling Pathway In Vitro.

Authors:  Chunling He; Dong Wang; Ruoling Wang; Yongli Huang; Xin Huang; ShuMin Shen; Jun Lv; Mingcai Wu
Journal:  Dose Response       Date:  2022-06-10       Impact factor: 2.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.